Parexel sets up BioPharm Unit to meet needs of SMEs
Will provide tailored services to speed drugs through development cycle
Parexel International, a global biopharmaceutical services provider, has set up the Parexel BioPharm Unit to focus solely on the needs of small and mid-sized biopharmaceutical companies to help them achieve their development goals.
The Parexel BioPharm Unit will support SMEs by providing the expertise, global infrastructure, operational excellence and turnkey technologies needed to help them advance their drugs through the development cycle. Its goal is to provide a tailored solution that accelerates development timelines, reduces costs and offers a high level of quality.
‘Small and mid-sized biopharmaceutical companies are truly the genesis of innovation and have been an important part of Parexel’s client base for more than 30 years,’ said Ubavka DeNoble, vice president of BioPharm Services.
‘The breadth and depth of our expertise gives us the ability to create customised solutions that are designed to meet the particular needs of each client – whether the company is a small research venture, a growing mid-sized business, or a global enterprise.’
